Clinical Trial

A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer

Study acronym: SWAP
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The aim of this study is to assess the safety and dosimetry of imaging with \[68Ga\]Ga-OncoACP3 in patients with prostate cancer.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-11
Trial Details
NCT Number NCT07600554
Lead Sponsor Philogen S.p.A.
Conditions Prostate Cancer
Enrollment 20 participants
Start Date 2026-05-27
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-10